BIND Therapeutics Inc Stock Nasdaq
Equities
US05548N1072
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Stephen Zale
CTO | Chief Tech/Sci/R&D Officer | 68 | 06-10-31 |
Tom Baker
IRC | Investor Relations Contact | - | - |
Neil Bander
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Corporate Officer/Principal | - | 16-07-23 |
1st Jan change | Capi. | |
---|---|---|
-0.62% | 105B | |
+4.13% | 97.5B | |
+1.63% | 22.19B | |
-15.47% | 21.33B | |
-7.96% | 18.68B | |
-41.41% | 16.6B | |
-20.80% | 14.52B | |
+7.19% | 14.09B | |
+22.63% | 10.99B |